Current Neuropharmacology
Journal Impact IF - Analysis · Trend · Prediction · Ranking


New

Journal Impact IF

2019-2020

4.668

2.2%

Journal Impact IF Trend

Related Journals

Popular Journals

Current Neuropharmacology

The 2019-2020 Journal Impact IF of Current Neuropharmacology is 4.668, which is just updated in 2020.

Current Neuropharmacology Impact Factor
Highest IF
4.668
Highest Journal Impact IF

The highest Journal Impact IF of Current Neuropharmacology is 4.668.

Lowest IF
2.031
Lowest Journal Impact IF

The lowest Journal Impact IF of Current Neuropharmacology is 2.031.

Total Growth Rate
64.0%
IF Total Growth Rate

The total growth rate of Current Neuropharmacology IF is 64.0%.

Annual Growth Rate
7.1%
IF Annual Growth Rate

The annual growth rate of Current Neuropharmacology IF is 7.1%.

Journal Impact IF Ranking

Subcategory Quartile Rank Percentile
Neurology Q1 19/155

Neurology 88%

Pharmacology (medical) Q1 15/237

Pharmacology (medical) 93%

Psychiatry and Mental Health Q1 28/506

Psychiatry and Mental Health 94%

Pharmacology Q1 30/301

Pharmacology 90%

Neurology (clinical) Q1 30/348

Neurology (clinical) 91%

Journal Impact IF Ranking

· In the Neurology research field, the Quartile of Current Neuropharmacology is Q1. Current Neuropharmacology has been ranked #19 over 155 related journals in the Neurology research category. The ranking percentile of Current Neuropharmacology is around 88% in the field of Neurology.
· In the Pharmacology (medical) research field, the Quartile of Current Neuropharmacology is Q1. Current Neuropharmacology has been ranked #15 over 237 related journals in the Pharmacology (medical) research category. The ranking percentile of Current Neuropharmacology is around 93% in the field of Pharmacology (medical).
· In the Psychiatry and Mental Health research field, the Quartile of Current Neuropharmacology is Q1. Current Neuropharmacology has been ranked #28 over 506 related journals in the Psychiatry and Mental Health research category. The ranking percentile of Current Neuropharmacology is around 94% in the field of Psychiatry and Mental Health.
· In the Pharmacology research field, the Quartile of Current Neuropharmacology is Q1. Current Neuropharmacology has been ranked #30 over 301 related journals in the Pharmacology research category. The ranking percentile of Current Neuropharmacology is around 90% in the field of Pharmacology.
· In the Neurology (clinical) research field, the Quartile of Current Neuropharmacology is Q1. Current Neuropharmacology has been ranked #30 over 348 related journals in the Neurology (clinical) research category. The ranking percentile of Current Neuropharmacology is around 91% in the field of Neurology (clinical).

Current Neuropharmacology Impact Factor 2020-2021 Prediction

Current Neuropharmacology Impact Factor Predition System

Current Neuropharmacology Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions
Total Publications
1122
Total Citations
38507

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

Journal Impact IF History

Year Journal Impact IF
Year Journal Impact IF
2019-2020 4.668
2018-2019 4.568
2017-2018 4.068
2016-2017 3.365
2015-2016 3.753
2014-2015 3.049
2013-2014 2.347
2012-2013 2.031
2011-2012 2.847
Journal Impact IF History

· The 2019-2020 Journal Impact IF of Current Neuropharmacology is 4.668
· The 2018-2019 Journal Impact IF of Current Neuropharmacology is 4.568
· The 2017-2018 Journal Impact IF of Current Neuropharmacology is 4.068
· The 2016-2017 Journal Impact IF of Current Neuropharmacology is 3.365
· The 2015-2016 Journal Impact IF of Current Neuropharmacology is 3.753
· The 2014-2015 Journal Impact IF of Current Neuropharmacology is 3.049
· The 2013-2014 Journal Impact IF of Current Neuropharmacology is 2.347
· The 2012-2013 Journal Impact IF of Current Neuropharmacology is 2.031
· The 2011-2012 Journal Impact IF of Current Neuropharmacology is 2.847

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
1983 0 2
1986 0 1
1988 0 1
1992 0 2
1993 0 1
1997 0 4
1998 0 1
1999 0 1
2000 0 2
2002 0 2
2003 27 13
2004 32 51
2005 23 94
2006 28 137
2007 27 176
2008 26 212
2009 36 450
2010 45 808
2011 102 1178
2012 34 1667
2013 53 2241
2014 46 2641
2015 75 2857
2016 116 3304
2017 144 4353
2018 63 4312
2019 79 5518
2020 155 7714
2021 8 764
Publications Cites Dataset

· The Current Neuropharmacology has published 0 reports and received 2 citations in 1983.
· The Current Neuropharmacology has published 0 reports and received 1 citations in 1986.
· The Current Neuropharmacology has published 0 reports and received 1 citations in 1988.
· The Current Neuropharmacology has published 0 reports and received 2 citations in 1992.
· The Current Neuropharmacology has published 0 reports and received 1 citations in 1993.
· The Current Neuropharmacology has published 0 reports and received 4 citations in 1997.
· The Current Neuropharmacology has published 0 reports and received 1 citations in 1998.
· The Current Neuropharmacology has published 0 reports and received 1 citations in 1999.
· The Current Neuropharmacology has published 0 reports and received 2 citations in 2000.
· The Current Neuropharmacology has published 0 reports and received 2 citations in 2002.
· The Current Neuropharmacology has published 27 reports and received 13 citations in 2003.
· The Current Neuropharmacology has published 32 reports and received 51 citations in 2004.
· The Current Neuropharmacology has published 23 reports and received 94 citations in 2005.
· The Current Neuropharmacology has published 28 reports and received 137 citations in 2006.
· The Current Neuropharmacology has published 27 reports and received 176 citations in 2007.
· The Current Neuropharmacology has published 26 reports and received 212 citations in 2008.
· The Current Neuropharmacology has published 36 reports and received 450 citations in 2009.
· The Current Neuropharmacology has published 45 reports and received 808 citations in 2010.
· The Current Neuropharmacology has published 102 reports and received 1178 citations in 2011.
· The Current Neuropharmacology has published 34 reports and received 1667 citations in 2012.
· The Current Neuropharmacology has published 53 reports and received 2241 citations in 2013.
· The Current Neuropharmacology has published 46 reports and received 2641 citations in 2014.
· The Current Neuropharmacology has published 75 reports and received 2857 citations in 2015.
· The Current Neuropharmacology has published 116 reports and received 3304 citations in 2016.
· The Current Neuropharmacology has published 144 reports and received 4353 citations in 2017.
· The Current Neuropharmacology has published 63 reports and received 4312 citations in 2018.
· The Current Neuropharmacology has published 79 reports and received 5518 citations in 2019.
· The Current Neuropharmacology has published 155 reports and received 7714 citations in 2020.
· The Current Neuropharmacology has published 8 reports and received 764 citations in 2021.
· The total publications of Current Neuropharmacology is 1122.
· The total citations of Current Neuropharmacology is 38507.

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

Current Neuropharmacology | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The Current Neuropharmacology Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Current Neuropharmacology during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Current Neuropharmacology.

History

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Use

The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor

Pros:

  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
Cons:
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.

Criticism

Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)

Current Neuropharmacology
Journal Profile

About

Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists. None

Highly Cited Keywords

ISSN
1570-159X
ISSN

The ISSN of Current Neuropharmacology is 1570-159X . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
1875-6190
ISSN (Online)

The ISSN (Online) of Current Neuropharmacology is 1875-6190 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Publisher
Bentham Science Publishers B.V.
Publisher

Current Neuropharmacology is published by Bentham Science Publishers B.V. .

Publication Frequency
-
Publication Frequency

Current Neuropharmacology publishes reports - .

Coverage
2004 - Present
Coverage

The Publication History of Current Neuropharmacology covers 2004 - Present .

Open Access
NO
Open Access

Current Neuropharmacology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Publication Fee

There is no publication fee for submiting manuscript to Current Neuropharmacology. Current Neuropharmacology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

Language
-
Language

The language of Current Neuropharmacology is - .

Country/Region
United Arab Emirates
Country/Region

The publisher of Current Neuropharmacology is Bentham Science Publishers B.V. , which locates in United Arab Emirates .

Selected Articles

Full Title Authors
Full Title Authors
Special Issue on Programmed Cell Death in Stroke Yağmur Çetin Taş · Ihsan Solaroglu · Yasemin Gursoy-Ozdemir · Yasemin Gursoy-Ozdemir
3D-QSAR and in-silico studies of natural products and related derivatives as monoamine oxidase inhibitors Lang-Yue Hu · Wen-Li Mi · Gen-Cheng Wu · Yan-Qing Wang · Qi-Liang Mao-Ying · Qi-Liang Mao-Ying
Pharmacological Treatment Of Body Dysmorphic Disorder Kinga Sałat · Beata Gryzło · Katarzyna Kulig · Katarzyna Kulig
Experimental drugs for neuropathic pain Dahua Fan · Liping Liu · Zhengzhi Wu · Meiqun Cao · Meiqun Cao
Combating neurodegenerative diseases with the plant alkaloid berberine: molecular mechanisms and therapeutic potential Sakire Pogun · Sakire Pogun
Editorial: Nicotine and the Nicotinic Cholinergic System in Health and Disease Hengli Zhao · Yujie Chen · Hua Feng · Hua Feng
P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke Di Li · Haibo Ni · Qin Rui · Rong Gao · Gang Chen · Gang Chen
Mst1: Function and Mechanism in Brain and Myocardial Ischemia Reperfusion Injury Debora Cutuli · Debora Cutuli
Editorial: In Silico Studies in Drug Research Against Neurodegenerative Diseases Xiyang Yao · Chenglin Liu · Dongxia Feng · Jun Yin · Gang Chen · Gang Chen
Transcranial Near-infrared Laser Therapy in Improving Cognitive Recovery of Function Following Traumatic Brain Injury Murad Atmaca · Murad Atmaca
Suicide risk in Obsessive-Compulsive Disorder and exploration of risk factors: a systematic review Olivia Tania Hernández-Hernández · Lucía Martínez-Mota · José Jaime Herrera-Pérez · Graciela Jiménez-Rubio · Graciela Jiménez-Rubio
Role of estradiol in the expression of genes involved in serotonin neurotransmission: Implications for female depression Talarico Giuseppina · Trebbastoni Alessandro · Bruno Giuseppe · Carlo de Lena · Carlo de Lena
Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimers Disease Faheem Hyder Pottoo · Noushad Javed · Md. Abul Barkat · Md. Sabir Alam · Javed Ashraf Nowshehri · Dhafer Mahdi Alshayban · Mohammad Azam Ansari · Mohammad Azam Ansari
Estrogen and Serotonin: Complexity of Interactions and Implications for Epileptic Seizures and Epileptogenesis De Francisco L · Costa Y · Priscila Miyuki Outuki · Raquel P. Souza · Patrícia de Souza Bonfim-Mendonça · Novello Cr · Marcia El Consolaro · Marcos Luciano Bruschi · Marcos Luciano Bruschi
The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments P. Sampedro-Piquero · P. Alvarez-Suarez · Azucena Begega · Azucena Begega
Coping with Stress During Aging: The Importance of a Resilient Brain Mohammed Shoaib · Yazead Buhidma · Yazead Buhidma
Role of physical exercise and omega-3 fatty acids on depressive illness in the elderly José Luis Cortes-Altamirano · Adriana Olmos-Hernández · Herlinda Bonilla Jaime · Paul Carrillo-Mora · Cindy Bandala · Samuel Reyes-Long · Alfonso Alfaro-Rodríguez · Alfonso Alfaro-Rodríguez
Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors Gerald Valentine and Mehmet Sofuoglu · Gerald Valentine and Mehmet Sofuoglu
Novel Therapeutics in Glaucoma Management Jochen Seitz · Kerstin Konrad · Beate Herpertz-Dahlmann · Beate Herpertz-Dahlmann
Extend, pathomechanism and clinical consequences of brain volume changes in anorexia nervosa Elżbieta Miller · Agnieszka Morel · Justyna Redlicka · Igor Miller · Joanna Saluk · Joanna Saluk
Pharmacological and non-pharmacological therapies of cognitive impairment in multiple sclerosis Anthony S. Zannas · Anthony S. Zannas
Gene-environment Interactions in Late Life: Linking Psychosocial Stress with Brain Aging Hikaru Takeuchi and Ryuta Kawashima · Hikaru Takeuchi and Ryuta Kawashima
Mean diffusivity in the dopaminergic system and neural differences related to dopaminergic system Morrone Luigi Antonio · Rombola Laura · Adornetto Annagrazia · Corasaniti Maria Tiziana · Russo Rossella · Russo Rossella
Functional Cross-Talk between Adenosine and Metabotropic Glutamate Receptors Kevin Hong · Vera Nezgovorova · Genoveva Uzunova · Danya Schlussel · Eric Hollander · Eric Hollander
Does ceruloplasmin defend against neurodegenerative diseases David Agustín León-Navarro · José Luis Albasanz · Mairena Martín · Mairena Martín
Glaucoma Pathogenesis and Neurotrophins: Focus on the Molecular and Genetic Basis for Therapeutic Prospects Bo Wang · Xiao-Ping Wang · Xiao-Ping Wang
Roles of TRAF6 in Central Nervous System Haibo Ni · Qin Rui · Di Li · Rong Gao · Gang Chen · Gang Chen
Programmed Cell Death after intracerebral hemorrhage F. Sarubbo · S. Esteban · A. Miralles · D. Moranta · D. Moranta
Differential Effects of Nicotine Exposure on the Hippocampus Across Lifespan Caroline Victorri-Vigneau · Andrew Spiers · Pascal Caillet · Mélanie Bruneau · IGNACE-consortium · Gaëlle Challet-Bouju · Marie Grall-Bronnec · Marie Grall-Bronnec
Functional Roles of the Ca2+-activated K+ Channel, KCa3.1, in Brain Tumors Catarina Chaves · Fernando Remião · Salvatore Cisternino · Xavier Declèves · Xavier Declèves
Potential medications or compounds acting on toll-like receptors in cerebral ischemia Giulio Perugi · Pierpaolo Medda · Cristina Toni · Chiara Socci · Mauro Mauri · Mauro Mauri
Closed-Loop Neuropharmacology For Epilepsy: Distant Dream Or Future Reality? Qin Rui · Haibo Ni · Di Li · Rong Gao · Gang Chen · Gang Chen
The Role of LRRK2 in Neurodegeneration of Parkinson Disease Sumit Jamwal and Puneet Kumar · Sumit Jamwal and Puneet Kumar
Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinsons Disease and Huntingtons Disease: A Review Maria Jesus Ramirez-Exposito and Jose Manuel Martinez-Martos · Maria Jesus Ramirez-Exposito and Jose Manuel Martinez-Martos
The delicate equilibrium between oxidants and antioxidants in brain glioma Emine Sekerdag · Ihsan Solaroglu · Yasemin Gursoy-Ozdemir · Yasemin Gursoy-Ozdemir
Cell Death Mechanisms in Stroke and Novel Molecular and Cellular Treatment Options Yang Dou · Xiaodi Tian · Jian Zhang · Zhong Wang · Gang Chen · Gang Chen
The Role of IRE1 Signaling in Central Nervous System Diseases Maria Luisa Rocco · Marzia Soligo · Luigi Manni · Luigi Aloe · Luigi Aloe
Necroptosis Signaling Pathways in Stroke: from Mechanisms to Therapies Nitin Chitranshi · Yogita Dheer · Mojdeh Abbasi · Yuyi You · Stuart L. Graham · Vivek Gupta · Vivek Gupta
Nerve Growth Factor: Early Studies and Recent Clinical Trials Ulf C. Schneider · Ran Xu · Peter Vajkoczy · Peter Vajkoczy
Inflammatory Events Following Subarachnoid Hemorrhage (SAH) Maja Przybyłowska · Szymon Kowalski · Krystyna Dzierzbicka · Iwona Inkielewicz-Stepniak · Iwona Inkielewicz-Stepniak
Therapeutic potential of multifunctional tacrine analogues Puneet Talwar · Renu Gupta · Suman Kushwaha · Rachna Agarwal · Luciano Saso · Shrikant Kukreti · Ritushree Kukreti · Ritushree Kukreti
Viral induced oxidative and inflammatory response in Alzheimers disease pathogenesis with identification of potential drug candidates: A systematic review using systems biology approach Luigi Catacuzzeno and Fabio Franciolini · Luigi Catacuzzeno and Fabio Franciolini
Editorial; The Role of Ca2+-activated K+ Channels of Intermediate Conductance in Glioblastoma Malignancy Luigi Sforna · Alfredo Megaro · Mauro Pessia · Fabio Franciolini · Luigi Catacuzzeno · Luigi Catacuzzeno
Structure, Gating and Basic Functions of the Ca2+-activated K Channel of Intermediate Conductance Elisabetta Burchi · Stefano Pallanti · Stefano Pallanti
Diagnostic Issues in Early-onset Obsessive-Compulsive Disorder and Their Treatment Implications Vini C. Sekhar · Gayathri Viswanathan · Sabulal Baby · Sabulal Baby
Insights into the molecular aspects of neuroprotective Bacoside A and Bacopaside I Yong Ku Kim · Yong Ku Kim
Editorial: Glia-Neuron Crosstalk and its Therapeutic Implication in Neuropsychiatric Disorders Huang Junlong · Li Yi · Zhao Bao-Lian · Li Jia-Si · Zhang Ning · Ye Zhouheng · Sun Xuejun · Liu Wenwu · Liu Wenwu
Rational Basis for Nutraceuticals in the Treatment of Glaucoma Dai-Qiang Liu · Ya-Qun Zhou · Feng Gao · Feng Gao
Functional and structural neural changes in obsessive-compulsive disorder after pharmacotherapy Umberto Albert · Diana De Ronchi · Giuseppe Maina · Maurizio Pompili · Maurizio Pompili
Different generations of type-B monoamine oxidase inhibitors in Parkinsons disease: from bench to bedside Ianara Mendonça Costa · Francisca Overlania V. Lima · Luciana Cristina B. Fernandes · Bianca Norrara · Francisca Idalina Neta · Rodrigo Dias Alves · José Rodolfo Lopes de Paiva Cavalcanti · Eudes Euler de Souza Lucena · Jeferson S. Cavalcante · Amália Cínthia Meneses Rêgo · Irami Araújo Filho · Dinalva Brito Queiroz · Marco Aurelio M. Freire · Fausto Pierdoná Guzen · Fausto Pierdoná Guzen
Aminopyridines and acetyl-DL-leucine: new therapies in cerebellar disorders Arti Rana · Shamsher Singh · Ruchika Sharma · Anoop Kumar · Anoop Kumar
Is the impact of starvation on the gut microbiota specific or unspecific to anorexia nervosa? A narrative review based on a systematic literature search Ianara Mendonça Costa · Marco Aurelio M. Freire · José Rodolfo Lopes de Paiva Cavalcanti · Dayane Pessoa de Araújo · Bianca Norrara · Isleania Maria Marques Moreira Rosa · Eduardo Pereira de Azevedo · Amália Cínthia Meneses Rêgo · Irami Araújo Filho · Fausto Pierdoná Guzen · Fausto Pierdoná Guzen
Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimers Disease: A Systematic Review István Bókkon · Birendra Nath Mallick · Birendra Nath Mallick
Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review Charlène Faye · Josephine C. McGowan · Christine A. Denny · Denis J. David · Denis J. David
New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs Francesco Paolo Busardò · Simona Pichini · Manuela Pellegrini · Angelo Montana · Alfredo Fabrizio Lo Faro · Simona Zaami · Silvia Graziano · Silvia Graziano
Premorbid and illness-related social difficulties in eating disorders: an overview of the literature and treatment developments István Bókkon · Birendra Nath Mallick · Birendra Nath Mallick
Updates on Genome-Wide Association Findings in Eating Disorders and Future Application to Precision Medicine Jonathan Hamill · Jaime E. C. Hallak · Serdar M. Dursun · Glen B. Baker · Glen B. Baker
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness Kamil Duris · Zbyněk Šplíchal · Michal Jurajda · Michal Jurajda
The Role of Inflammatory Response in Stroke Associated Programmed Cell Death Shilpa Sharma and Ravi Shankar Akundi · Shilpa Sharma and Ravi Shankar Akundi
Mitochondria: A Connecting Link In The Major Depressive Disorder Jigsaw Wenlu Li · Zhigang Chen · Ian Chin · Zhong Chen · Haibin Dai · Haibin Dai
The role of VE-cadherin in blood-brain barrier integrity under central nervous system pathological conditions P. Sampedro-Piquero and R.D. Moreno-Fernandez · P. Sampedro-Piquero and R.D. Moreno-Fernandez
Editorial: Brain Basis of Resilience and its Effect on Mood Disorders in the Aging Akhil Kumar · Ashish Tiwari · Ashok Sharma · Ashok Sharma
Changing paradigm from one target one ligand towards multi target directed ligand design for key drug targets of Alzheimer disease: An important role of Insilco methods in multi target directed ligands design Sheikh Arslan Sehgal · Mirza Ahmed Hammad · Rana Adnan Tahir · Hafiza Nisha Akram · Faheem Ahmad · Faheem Ahmad
Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design Giacinto Bagetta · Rossella Russo · Rossella Russo
Glaucoma: In Search of Better Neurotherapeutics Pouran Makhdoumi · Mojtaba Limoee · Ghulam Md Ashraf · Hooshyar Hossini · Hooshyar Hossini
Molecular Mechanism of Aniline Induced Spleen Toxicity and neuron toxicity in experimental rat exposure: A review Antonio Del Casale · Serena Sorice · Alessio Padovano · Maurizio Simmaco · Stefano Ferracuti · Dorian A. Lamis · Chiara Rapinesi · Gabriele Sani · Paolo Girardi · Georgios D. Kotzalidis · Maurizio Pompili · Maurizio Pompili
Psychopharmacological treatment of Obsessive-Compulsive Disorder (OCD) Melina A. Throuvala · Mark D. Griffiths · Mike Rennoldson · Daria J. Kuss · Daria J. Kuss
School-based prevention for adolescent Internet addiction: prevention is the key. A systematic literature review Stephan Zipfel · Ulrike Schmidt · Ulrike Schmidt
Psychobiology of Eating Disorders – a Gateway to Precision Medicine Aribert Rothenberger and Veit Roessner · Aribert Rothenberger and Veit Roessner
Psychopharmacotherapy of Obsessive-compulsive Symptoms within the Framework of Tourette Syndrome Marika Alborghetti and Ferdinando Nicoletti · Marika Alborghetti and Ferdinando Nicoletti
Astragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic Review Hiroshi Mitoma · Mario Manto · Christiane S. Hampe · Christiane S. Hampe
Immune-mediated cerebellar ataxias: Practical guidelines and therapeutic challenges Yulia Sidorova · Konstantin P. Volcho · Nariman F. Salahytdinov · Nariman F. Salahytdinov
Neuroregeneration in Parkinsons Disease: From Proteins to Small Molecules Muneeb U. Rehman · Adil Farooq Wali · Anas Ahmad · Sheeba Shakeel · Saiema Rasool · Rayeesa Ali · Shazada Mudasir Rashid · Hassan Madkhali · Majid Ahmad Ganaie · Rehan Khan · Rehan Khan
Neuroprotective Strategies for Neurological Disorders by Natural Products: An update Roger Kalla · Michael Strupp · Michael Strupp
Neurostimulation in clinical and sub-clinical eating disorders: a systematic update of the literature Isabelle Mack · John Penders · Jessica Cook · Jaslyn Dugmore · Nazar Mazurak · Paul Enck · Paul Enck
Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population Deniz Bagdas · Mine Sibel Gurun · Pamela Flood · Roger L. Papke · M. Imad Damaj · M. Imad Damaj
Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights Guanghao Yin · Gang Yao · Kun Zhang · Bingjin Li · Bingjin Li
QSAR Modeling of Histamine H3R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases Jairo Vinícius Pinto · Ives Cavalcante Passos · Diego Librenza-Garcia · Grasiela Marcon · Maiko Abel Schneider · Joao Henrique Conte · Joao Pedro Abreu da Silva · Luiza Pereira Lima · André Quincozes-Santos · Marcia Kauer-Sant’Anna · Flavio Kapczinski · Flavio Kapczinski
Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development Gjumrakch Aliev · Ghulam Md Ashraf · Vadim V. Tarasov · Vladimir N. Chubarev · Jerzy Leszek · Kazimierz Gasiorowski · Alfiya Makhmutovа · Saleh S. Baeesa · Marco Avila-Rodriguez · Aleksey A. Ustyugov · S. O. Bachurin · S. O. Bachurin
Traumatic Brain Injury altered Normal Brain Signaling Pathways: Implications for Novel Therapeutics approaches Carmen Peña-Bautista · Miguel Baquero · Máximo Vento · Consuelo Cháfer-Pericás · Consuelo Cháfer-Pericás
Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders Hamilton M. Ishiki · José Maria Barbosa Filho · Marcelo Sobral da Silva · Marcus T. Scotti · Luciana Scotti · Luciana Scotti
Oxytocin and eating disorders: a narrative review on emerging findings and perspectives Yong-Ku Kim and Sang Won Jeon · Yong-Ku Kim and Sang Won Jeon
Alzheimer: A Decade of Drug Design. Why Molecular Topology can be an Extra Edge Soumen Khatua · Anne Song · Divyaswathi Citla Sridhar · Stephen C. Mack · Stephen C. Mack
Alzheimer Disease – Future Therapy Based on Dendrimers Qin Hu · Qin Hu
Pros and cons of medical cannabis use by people with chronic brain disorders Hagop S. Akiskal · Hagop S. Akiskal
Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides during the Stress Response Xin Li · Yang Lin · Gang Yao · Yicun Wang · Yicun Wang
Three-dimensional modelling of the voltage-gated sodium ion channel from Anopheles gambiae reveals spatial clustering of evolutionarily conserved acidic residues at the extracellular sites Sahila Mohammed Marunnan · Babitha Pallikkara Pulikkal · Anitha Jabamalairaj · Srinivas Bandaru · Mukesh Yadav · Anuraj Nayarisseri · Victor Arokia Doss · Victor Arokia Doss
INTRODUCTORY CONSIDERATIONS Athanasios Koukopoulos: The Man, the Psychiatrist, the Original Thinker Burcu Balkan · Sakire Pogun · Sakire Pogun
Pharmacogenetics and pharmacotherapy of military personnel suffering from posttraumatic stress disorder Flaminia Pantano · Roberta Tittarelli · Giulio Mannocchi · Roberta Pacifici · Alessandro di Luca · Francesco Paolo Busardò · Enrico Marinelli · Enrico Marinelli
Development of MLR and SVM Aided QSAR Models to Identify Common SAR of GABA Uptake Herbal Inhibitors used in the Treatment of Schizophrenia Hong-Jiang Li · Zhao-Liang Sun · Xi-Tao Yang · Liang Zhu · Dong-Fu Feng · Dong-Fu Feng
Exploring optic nerve axon regeneration Priya Jhelum · Bhanu Chandra Karisetty · Arvind Kumar · Sumana Chakravarty · Sumana Chakravarty
Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models Nazgol Motamed-Gorji · Nassim Matin · Omidreza Tabatabaie · Piero Pavone · Catia Romano · Raffaele Falsaperla · Giovanna Vitaliti · Giovanna Vitaliti
Biological Drugs in Guillain-Barré Syndrome: An Update Sylvie Tordjman · Sylvie Chokron · Richard Delorme · Annaëlle Charrier · Eric Bellissant · Nemat Jaafari · Claire Fougerou · Claire Fougerou
Melatonin: Pharmacology, Functions and Therapeutic Benefits Shuai Yang · Hui-Juan Jin · Yi-Yi Zhu · Yan Wan · Elvis Nana Opoku · Ling-Qiang Zhu · Bo Hu · Bo Hu
Diverse Functions and Mechanisms of Pericytes in Ischemic Stroke Marcos L. Aranda · María Florencia González Fleitas · Hernán Dieguez · Agustina Iaquinandi · Pablo Sande · Damián Dorfman · Ruth E. Rosenstein · Ruth E. Rosenstein
Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases Lilian Aly · Bernhard Hemmer · Thomas Korn · Thomas Korn
From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis Maykel Cruz-Monteagudo · Maykel Cruz-Monteagudo · Fernanda Borges · M. Natália D. S. Cordeiro · Aliuska Morales Helguera · Eduardo Tejera · César Paz-y-Miño · Aminael Sánchez-Rodríguez · Yunier Perera-Sardiña · Yunierkis Pérez-Castillo · Yunierkis Pérez-Castillo
Chemoinformatics profiling of the chromone nucleus as a MAO-B/A2AAR dual binding scaffold Murali Aarthy · Umesh Panwar · Chandrabose Selvaraj · Sanjeev Kumar Singh · Sanjeev Kumar Singh
The Influence of Vaccine on Febrile Seizure Camille Loiseau · Florence Cayetanot · Fanny Joubert · Anne-Sophie Perrin-Terrin · Philippe Cardot · Marie-Noëlle Fiamma · Alain Frugière · Christian Straus · Laurence Bodineau · Laurence Bodineau
Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant? Giuseppina D’Alessandro · Cristina Limatola · Myriam Catalano · Myriam Catalano
Current perspectives for the use of gonane progesteronergic drugs in the treatment of central hypoventilation syndromes Dana Zeid · Munir Gunes Kutlu · Thomas J. Gould · Thomas J. Gould
Evolutionary considerations on the emerging subculture of the E-psychonauts and the novel psychoactive substances: A comeback to the shamanism? Karen Manoutcharian · Roxanna Perez-Garmendia · Goar Gevorkian · Goar Gevorkian
Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs Jeremy Carlier · Xingxing Diao · Ariane Wohlfarth · Karl B. Scheidweiler · Marilyn A. Huestis · Marilyn A. Huestis
Neurotoxicity Induced by Mephedrone: An up-to-date Review Laura Orsolini · Paul St John-Smith · Daniel McQueen · Duccio Papanti · John Corkery · Fabrizio Schifano · Fabrizio Schifano
Recent trends in analytical methods to determine new psychoactive substances in hair Nadine Schaefer · Mattias Kettner · Matthias W. Laschke · Julia Schlote · Andreas H. Ewald · Michael D. Menger · Hans H. Maurer · Peter H. Schmidt · Peter H. Schmidt
In Silico Studies in Drug Research Against Neurodegenerative Diseases Katarzyna Zorena · Katarzyna Zorena
Revisiting antipsychotic-induced akathisia: current issues and prospective challenges Shigeyuki Chaki · Shigeyuki Chaki
WhenChemsMeet Sex: A Rising Phenomenon CalledChemSex Farahnaz Rezaei Makhouri · Jahan B. Ghasemi · Jahan B. Ghasemi
Recombinant Antibody Fragments for Neurodegenerative Diseases Rithvik S. Vinekar · Ramanathan Sowdhamini · Ramanathan Sowdhamini
In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid Janine Naß · Thomas Efferth · Thomas Efferth
KCa3.1 channels and glioblastoma: in vitro studies Raffaele Giorgetti · Adriano Tagliabracci · Fabrizio Schifano · Simona Zaami · Enrico Marinelli · Francesco Paolo Busardò · Francesco Paolo Busardò
Neuroprotective role of Agmatine in Neurological Diseases Lukas Klumpp · Efe C. Sezgin · Marco Skardelly · Franziska Eckert · Stephan M. Huber · Stephan M. Huber
Stress, Depression, Resilience and Ageing: A Role for the LPA-LPA1 Pathway Weilin Xu · Liansheng Gao · Tao Li · Anwen Shao · Zhang J · Zhang J
Polyphenols Beyond Barriers: A Glimpse into the Brain Ben-Skowronek Iwona · Ben-Skowronek Iwona
Insights Into Nicotinic Receptor Signaling in Nicotine Addiction: Implications for Prevention and Treatment Inês Figueira · Regina Menezes · Diana Macedo · Inês Costa · Cláudia N. Santos · Cláudia N. Santos
Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain Wuyi Liu and Ming D. Li · Wuyi Liu and Ming D. Li
Advantages of Structure-Based Drug design Approaches in Neurological Disorders Haitham Salem · Caesa Nagpal · Teresa A. Pigott · Antônio Lúcio Teixeira · Antônio Lúcio Teixeira
Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms Wing-Mann Ho · Onat Akyol · Haley Reis · Cesar Reis · Devin W. McBride · Claudius Thomé · John H. Zhang · John H. Zhang
Beyond Ketamine: New Approaches to the Development of Safer Antidepressants Zoltan Rihmer · Xenia Gonda · Peter Dome · Peter Dome
Editorial: Recent Advances in Pathophysiological Studies and Treatment of Epilepsy Nobuhisa Iwata · Nobuhisa Iwata
Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 Receptors and their Role in the Modulation of Pain Response in the Central Nervous System Mohammad Hassan Baig · Khurshid Ahmad · Gulam Rabbani · Mohd Danishuddin · Inho Choi · Inho Choi
Computer Aided Drug Design and its Application to the Development of Potential Drugs for Neurodegenerative Disorders Michele Zoli · Susanna Pucci · Antonietta Vilella · Cecilia Gotti · Cecilia Gotti
Cognitive Effects of Nicotine: Recent Progress Mahadevabharath R. Somayaji · Andrzej Przekwas · Raj K. Gupta · Raj K. Gupta
Combination Therapy for Multi-Target Manipulation of Secondary Brain Injury Mechanisms Trevor Steward · José M. Menchón · Susana Jiménez-Murcia · Carles Soriano-Mas · Fernando Fernández-Aranda · Fernando Fernández-Aranda
Neural network alterations across eating disorders: a narrative review of fMRI studies Elise E. DeVito and Suchitra Krishnan-Sarin · Elise E. DeVito and Suchitra Krishnan-Sarin
E-cigarettes: Impact of E-Liquid Components and Device Characteristics on Nicotine Exposure Rosanna Chianese · Roberto Coccurello · Andrea Viggiano · Marika Scafuro · Marco Fiore · Giangennaro Coppola · Francesca Felicia Operto · Silvia Fasano · Sophie Layé · Riccardo Pierantoni · Rosaria Meccariello · Rosaria Meccariello
Impact of Dietary Fats on Brain Functions Alla P. Toropova · Andrey A. Toropov · Sanija Begum · Patnala Ganga Raju Achary · Patnala Ganga Raju Achary
Blood Brain Barrier and Alzheimers Disease: Similarity and Dissimilarity of Molecular Alerts Miao-Kun Sun · Miao-Kun Sun
Potential Therapeutics for Vascular Cognitive Impairment and Dementia Katalin Monostory · Andrea Nagy · Katalin Tóth · Tamas Budi · Ádám Kiss · Máté Déri · Gábor Csukly · Gábor Csukly
Relevance of CYP2C9 Function in Valproate Therapy Claudio Bucolo · Chiara Bianca Maria Platania · Filippo Drago · Vincenza Bonfiglio · Michele Reibaldi · Teresio Avitabile · Maurizio G. Uva · Maurizio G. Uva
Imaging the role of inflammation in mood and anxiety-related disorders Riccardo Zanni · Ramón García-Domenech · María Gálvez-Llompart · Jorge Gálvez · Jorge Gálvez
Editorial: Improving Neuropharmacology using Big Data, Machine Learning and Computational Algorithms Jennifer C. Felger · Jennifer C. Felger
Mechanisms of Melatonin in Alleviating Alzheimers Disease Khader Shameer · Anuraj Nayarisseri · Francisco Xavier Romero Duran · Humberto González-Díaz · Humberto González-Díaz
Computer-aided drug design applied to Parkinson targets Mayuri Shukla · Piyarat Govitrapong · Parichart Boontem · Russel J. Reiter · Jutamaad Satayavivad · Jutamaad Satayavivad
Targeting cytokines for morphine tolerance: a narrative review Priyanka Dhiman · Neelam Malik · Anurag Khatkar · Anurag Khatkar
Why are Antidepressant Drugs Effective Smoking Cessation Aids Stefano Farioli-Vecchioli · Stefano Sacchetti · Vittoria Nicolis di Robilant · Debora Cutuli · Debora Cutuli
Meet Our Regional Editor Simone Pisano · Marco Pozzi · Gennaro Catone · Giulia Scrinzi · Emilio Clementi · Giangennaro Coppola · Annarita Milone · Carmela Bravaccio · Paramala Santosh · Gabriele Masi · Gabriele Masi
Is mania the hypertension of the mood? Discussion of a hypothesis Paweł Muszyński · Magdalena Groblewska · Agnieszka Kulczyńska-Przybik · Alina Kułakowska · Barbara Mroczko · Barbara Mroczko
Putative mechanisms of action and clinical use of lithium in children and adolescents: a critical review Michelle Fidelis Corrêa · João P. S. Fernandes · João P. S. Fernandes
YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimers Disease Rajeev K Singla · Luciana Scotti · Ashok K. Dubey · Ashok K. Dubey
In Silico Studies Revealed Multiple Neurological Targets for the Antidepressant Molecule Ursolic Acid Roberta Celli · Ines Santolini · Michela Guiducci · Gilles van Luijtelaar · Pasquale Parisi · Pasquale Striano · Roberto Gradini · Giuseppe Battaglia · Richard Teke Ngomba · Ferdinando Nicoletti · Ferdinando Nicoletti
The Α2δ subunit and absence epilepsy: beyond calcium channels? Gabriele Sani · Georgios D. Kotzalidis · Paolo Girardi · Paolo Girardi
EDITORIAL:The Faces of Mania: The Legacy of Athanasios Koukopoulos Simona Pichini · Francesco Paolo Busardò · Roberta Pacifici · Pascal Kintz · Pascal Kintz
New psychoactive substances (Nps), a new global issue: Neuropharmacological, chemical and toxicological aspects Erik Wibowo · Erik Wibowo
Cognitive Impacts of Estrogen Treatment in Androgen-Deprived Males: What Needs to be Resolved Elżbieta Rębas · Tomasz Radzik · Tomasz Boczek · Ludmila Zylinska · Ludmila Zylinska
Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids Miroslav Adzic · Zeljka Brkic · Milos Mitic · Ester Francija · Milica Jovicic · Jelena Radulovic · Nadja P. Maric · Nadja P. Maric
Therapeutic strategies for treatment of inflammation-related depression Irene Aicua-Rapun · Pascal André · Jan Novy · Jan Novy
Autophagy after Subarachnoid Hemorrhage: Can Cell Death be Good? Katrin Elisabeth Giel · Stephan Zipfel · Manfred Hallschmid · Manfred Hallschmid
NGF and BDNF Alterations by Prenatal Alcohol Exposure Valentina Cardi · Kate Tchanturia · Janet Treasure · Janet Treasure
Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs Valentina Carito · Mauro Ceccanti · Giampiero Ferraguti · Roberto Coccurello · Stefania Ciafrè · Paola Tirassa · Marco Fiore · Marco Fiore
Neuroprotection mechanisms and their potential applications Luciana Scotti · Luciana Scotti
Herbal Highs: Review on Psychoactive Effects and Neuropharmacology Manuela Pellegrini · Maria Concetta Rotolo · Francesco Paolo Busardò · Roberta Pacifici · Simona Pichini · Simona Pichini
Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder Bethan Dalton · Savani Bartholdy · Iain C. Campbell · Ulrike Schmidt · Ulrike Schmidt
Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder Zoya Marinova · De-Maw Chuang · Naomi Fineberg · Naomi Fineberg
Non-allowed pharmacologically active substances in physical and sexual performance enhancing products Luigi Antonio Morrone · Damiana Scuteri · Laura Rombolà · Hirokazu Mizoguchi · Giacinto Bagetta · Giacinto Bagetta
Opioids Resistance in Chronic Pain Management Uma Suryadevara · Dawn Bruijnzeel · Meena Nuthi · Darin A. Jagnarine · Rajiv Tandon · Adriaan W. Bruijnzeel · Adriaan W. Bruijnzeel
Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases Silvia Graziano · Laura Orsolini · Maria Concetta Rotolo · Roberta Tittarelli · Fabrizio Schifano · Simona Pichini · Simona Pichini
Genetic Risk Factors for Glaucoma and Exfoliation Syndrome Identified by Genome-wide Association Studies Cinzia Rapino · Daniel Tortolani · Lucia Scipioni · Mauro Maccarrone · Mauro Maccarrone
Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity Maksim V. Storozhuk · A Zholos · A Zholos
EDITORIAL: Neuroprotection Mechanisms and their Potential Applications Erin W Tuplin and Matthew R Holahan · Erin W Tuplin and Matthew R Holahan
Epigenetic Regulation of Memory-Therapeutic Potential for Disorders Debora Cutuli · Debora Cutuli
The Role of Autophagy in Subarachnoid Hemorrhage: An Update Padmanabh Singh · Sweta Srivas · M. K. Thakur · M. K. Thakur
Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology Yuanjian Fang · Sheng Chen · Cesar Reis · Zhang J · Zhang J
Depression and Mania in Bipolar Disorder Vivekkumar P. Dadhania · Priyanka Trivedi · Ajit Vikram · Durga Nand Tripathi · Durga Nand Tripathi
Free Interval Duration: Clinical Evidence of the Primary Role of Excitement in Bipolar Disorder Ilker Y. Eyüpoglu · Nicolai E. Savaskan · Nicolai E. Savaskan
Acetylcholinesterase inhibitors and drugs acting on muscarinic receptors - potential crosstalk of cholinergic mechanisms during pharmacological treatment Gabriele Sani · Alessio Simonetti · Daniela Reginaldi · Alexia E. Koukopoulos · Antonio Del Casale · Giovanni Manfredi · Georgios D. Kotzalidis · Paolo Girardi · Paolo Girardi
TUMOUR-DERIVED GLUTAMATE: LINKING ABERRANT CANCER CELL METABOLISM TO PERIPHERAL SENSORY PAIN PATHWAYS Chi Hsien Huang · Chia Chen Huang · Cheuk-Kwan Sun · Gong Hong Lin · Wen Hsuan Hou · Wen Hsuan Hou
The Proteomics of Intrathecal Analgesic agents for Chronic Pain Amy Lee Bredlau · Suraj Dixit · Chao Chen · Ann-Marie Broome · Ann-Marie Broome
Evidences for the anti-panic actions of Cannabidiol Kenneth Blum · Marcelo Febo · Rajendra D. Badgaiyan · Zsolt Demetrovics · Thomas Simpatico · Claudia Fahlke · Marlene Oscar-Berman · Mona Li · Kristina Dushaj · Mark S. Gold · Mark S. Gold
Molecular Hydrogen as a Neuroprotective Agent Marco Bisaglia · Marco Bisaglia
Positive Social Interactions in a Lifespan Perspective with a focus on Opioidergic and Oxytocinergic systems: Implications for Neuroprotection Abhay Sharma · Abhay Sharma
Antidepressant-induced Dopamine Receptor Dysregulation: A Valid Animal Model of Manic-Depressive Illness Valentina Colonnello · Valentina Colonnello · Nicola Petrocchi · Marina Farinelli · Cristina Ottaviani · Cristina Ottaviani
Parental Reports of Prodromal Psychopathology in Pediatric Bipolar Disorder Ashutosh Kumar · Ashutosh Kumar
5-HT3 Receptors: A Potential Therapeutic Target for Epilepsy Yi-Qun Wang · Meng-Qi Zhang · Rui Li · Wei-Min Qu · Zhi-Li Huang · Zhi-Li Huang
Neurobiological Evidence for the Primacy of Mania Hypothesis Libby Infinger · Charles B. Stevenson · Charles B. Stevenson
MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments? Yashika Bansal · Anurag Kuhad · Anurag Kuhad
The long run: neuroprotective effects of physical exercise on adult neurogenesis from youth to old age Amol D. Jadhav · Li Wei · Peng Shi · Peng Shi
Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities Daniele Saraulli · Marco Costanzi · Valentina Mastrorilli · Stefano Farioli-Vecchioli · Stefano Farioli-Vecchioli
The Pharmacology of Spinal Opioids and Ziconotide for the Treatment of Non-Cancer Pain James A. R. Dalton · Isaias Lans · Xavier Rovira · Fanny Malhaire · Xavier Gómez-Santacana · Silvia Pittolo · Pau Gorostiza · Amadeu Llebaria · Cyril Goudet · Jean-Philippe Pin · Jesús Giraldo · Jesús Giraldo
Functional and Structural Benefits Induced by Omega-3 Polyunsaturated Fatty Acids During Aging Evelyn Kahl · Markus Fendt · Markus Fendt
Pediatric mania: the controversy between euphoria and irritability Kohei Koga · Shermaine Li · Min Zhuo · Min Zhuo
Ziconotide Monotherapy: A Systematic Review of Randomised Controlled Trials Haiyan Lu · Weidong Le · Ya Ying Xie · Xiao Ping Wang · Xiao Ping Wang
The Role of Oxidative Stress in Methamphetamine-induced Toxicity and Sources of Variation in the Design of Animal Studies Dolores Sgambato · Annalisa Capuano · Maria Giuseppa Sullo · Agnese Miranda · Alessandro Federico · Marco Romano · Marco Romano
Neuroprotective effects of exercise treatments after injury: the dual role of neurotrophic factors Szmygel Ł · Kosiak W · Katarzyna Zorena · Małgorzata Myśliwiec · Małgorzata Myśliwiec
Environmental Enrichment as a Positive Behavioral Intervention Across the Lifespan Stefano Cobianchi · Ariadna Arbat-Plana · Víctor López-Alvarez · Xavier Navarro · Xavier Navarro
Current and Future Issues in the development of spinal agents for the management of pain Sampedro-Piquero P · Begega A · Begega A
Chlorogenic Acid and Mental Diseases: From Chemistry to Medicine Roberta Filograna · Mariano Beltramini · Luigi Bubacco · Marco Bisaglia · Marco Bisaglia
Psychotic Symptoms Associated with the use of Dopaminergic Drugs, in Patients with Cocaine Dependence or Abuse Feng Qian · Feng-Ru Tang · Feng-Ru Tang
TRP channels as novel targets for endogenous ligands: focus on endocannabinoids and nociceptive signalling Hongyan Zhao · Yang Lin · Shurui Chen · Xin Li · Hongliang Huo · Hongliang Huo
Advances in the Physiology of GPR55 in the Central Nervous System Francesca Demontis · Francesca Serra · Gino Serra · Gino Serra
The Mutual Interaction Between Sleep and Epilepsy on the Neurobiological Basis and Therapy Minwoo Lee · Bo Young Choi · Sang Won Suh · Sang Won Suh
Unexpected Effects of Acetylcholine Precursors on Pilocarpine Seizure- Induced Neuronal Death Ivana Grković · Dunja Drakulić · Jelena Martinović · Nataša Mitrović · Nataša Mitrović
Drug-Resistant Epilepsy and Surgery Anna Fracassi · Martina Marangoni · Pamela Rosso · Valentina Pallottini · Marco Fioramonti · Silvia Siteni · Marco Segatto · Marco Segatto
Statins and the Brain: More than Lipid Lowering Agents? Spyridon Siafis · Dimitrios Tzachanis · Myrto Samara · Georgios Papazisis · Georgios Papazisis
The Infectious Etiology of Alzheimers Disease Vincenzo Parisi · Francesco Oddone · Lucia Ziccardi · Gloria Roberti · Gianluca Coppola · Gianluca Manni · Gianluca Manni
The Challenge of microRNA as a Biomarker of Epilepsy Pascal Kintz · Pascal Kintz
Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function Tobias Bobinger · Petra Burkardt · Hagen B. Huttner · Anatol Manaenko · Anatol Manaenko
Effects of Resveratrol and other Polyphenols on Sirt1: Relevance to Brain Function During Aging Guangfan Chi · Zhehao Huang · Xianglan Li · Kun Zhang · Guangquan Li · Guangquan Li
Recent Advances in Pathophysiology of Traumatic Brain Injury Rainer Kraehenmann · Rainer Kraehenmann
Substance P Regulation in Epilepsy Maria Dolores Pinazo-Duran · Kian Shoaie-Nia · Vicente Zanon-Moreno · Silva M. Sanz-Gonzalez · Javier Benitez del Castillo · Jose Javier Garcia-Medina · Jose Javier Garcia-Medina
Strategies to Reduce Oxidative Stress in Glaucoma Patients Jaume Folch · Oriol Busquets · Miren EttchetoElena Sánchez-López · Mercè Pallàs · Carlos Beas-Zarate · Miguel Marin · Gemma Casadesus · Jordi Olloquequi · Carme Auladell · Antoni Camins · Antoni Camins
Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects Jang Ho Lee · Jeong-Hoon Kim · Sunhong Kim · Kyoung Sang Cho · Sung Bae Lee · Sung Bae Lee
Chromatin Changes Associated with Neuronal Maintenance and Their Pharmacological Application Brandon M. Brown · Brandon Pressley · Heike Wulff · Heike Wulff
Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation Jiyao Sheng · Shui Liu · Hanjiao Qin · Bingjin Li · Xuewen Zhang · Xuewen Zhang
Experimental models for aging and their potential for novel drug discovery Yoichi Sakurada · Fumihiko Mabuchi · Fumihiko Mabuchi
New psychoactive substances 3-methoxyphencyclidine (3-MeO-PCP) and 3-methoxyrolicyclidine (3-MeO-PCPy): metabolic fate elucidated with rat urine and human liver preparations and their detectability in urine by GC-MS, LC-(high resolution)-MSn, and LC-high resolution-MS/MS Gabriele Sani · Georgios D. Kotzalidis · Paolo Girardi · Paolo Girardi
Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications Gislaine Z. Réus · Airam B. de Moura · Ritele H. Silva · Wilson R. Resende · João Quevedo · João Quevedo
The Progress of Epilepsy after Stroke Julian A. Michely · Sascha K. Manier · Achim T. Caspar · Simon D. Brandt · Jason Wallach · Hans H. Maurer · Hans H. Maurer
Role of Ectonucleotidases in the Synapse Formation During Brain Development: Physiological and Pathological Implications Yifan Zhang · Jingwei Xu · Kun Zhang · Wei Yang · Bingjin Li · Bingjin Li
The Anticonvulsant Effects of Ketogenic Diet on Epileptic Seizures and Potential Mechanisms Marco De Carli · Shivakumar Kolachalam · Stefano Aringhieri · Mario Rossi · Luca Giovannini · Roberto Maggio · Marco Scarselli · Marco Scarselli
Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them? Stephen M. Manchishi · Stephen M. Manchishi
Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development Man Li · Jing Liu · Ying Bi · Jixiang Chen · Lei Zhao · Lei Zhao
Evidence of 2 Populations of Mephedrone Abusers by Hair Testing. Application to 4 Forensic Expertises Marta Sochocka · Katarzyna Zwolińska · Jerzy Leszek · Jerzy Leszek
Kca3.1 channel modulators as potential therapeutic compounds for glioblastoma Yihong Ma · Yihong Ma
Recent Advances in Antiepileptic Herbal Medicine Botond Penke · Lívia Fülöp · Mária Szücs · Ede Frecska · Ede Frecska
The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features Yinghao Zhao · Xiangyan Li · Kun Zhang · Ti Tong · Ranji Cui · Ranji Cui
The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases Etsuko Shimobayashi and Josef P. Kapfhammer · Etsuko Shimobayashi and Josef P. Kapfhammer
Neuroprotection by Estrogen and Progesterone in Traumatic Brain Injury and Spinal Cord Injury Anil Gulati · Anil Gulati
D-cycloserine in schizophrenia: New strategies for improving clinical outcomes by enhancing plasticity Eric S. Wohleb · Danielle M. Gerhard · Alex Thomas · Ronald S. Duman · Ronald S. Duman
Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine Roger A. Kroes · Carol L. Nilsson · Carol L. Nilsson
Towards the Molecular Foundations of Glutamatergic-targeted Antidepressants Wen-Jie Li · Chen Chen · Zhi-Fei You · Ren-Min Yang · Xiao-Ping Wang · Xiao-Ping Wang
Current Drug Managements of Wilsons Disease: From West to East Pilar Rivero-Ríos · Jesús Madero-Pérez · Belén Fernández · Sabine Hilfiker · Sabine Hilfiker
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease Evgeni Brotfain · Shaun E. Gruenbaum · Matthew Boyko · Ruslan Kutz · Alexander Zlotnik · Moti Klein · Moti Klein
Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis Joseph R. Moskal · Jeffrey Burgdorf · Patric K. Stanton · Roger A. Kroes · John F. Disterhoft · Ronald M. Burch · M. Amin Khan · M. Amin Khan
Endothelin Receptors, Mitochondria and Neurogenesis in Cerebral Ischemia S.W. Tsang · K.K. W. Auyeung · Z.X. Bian · J.K.S. Ko · J.K.S. Ko
The Development of Rapastinel (Formerly GLYX-13); a rapid acting and long lasting antidepressant Frank M. Schmidt · Kc Kirkby · Nicole Lichtblau · Nicole Lichtblau
Inflammation and immune regulation as potential drug targets in antidepressant treatment Ji-chun Zhang · Wei Yao · Kenji Hashimoto · Kenji Hashimoto
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia Rebecca K. Senter · Ayan Ghoshal · Adam G. Walker · Zixiu Xiang · Colleen M. Niswender · P. Jeffrey Conn · P. Jeffrey Conn
Metabotropic Glutamate Receptor Dependent Cortical Plasticity in Chronic Pain Carlo Maj · Alessandra Minelli · Edoardo Giacopuzzi · Emilio Sacchetti · Massimo Gennarelli · Massimo Gennarelli
The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders Giulia Serra · Mai Uchida · Claudia Battaglia · Maria Pia Casini · Lavinia De Chiara · Joseph Biederman · Stefano Vicari · Janet Wozniak · Janet Wozniak
Group I Metabotropic Glutamate Receptor Interacting Proteins: Fine-Tuning Receptor Functions in Health and Disease Daniel Peterlik · Peter J. Flor · Nicole Uschold-Schmidt · Nicole Uschold-Schmidt
Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression Joanna Kadłubowska · Lucia Malaguarnera · Piotr Wąż · Katarzyna Zorena · Katarzyna Zorena
Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss Stephen M. Fitzjohn · Zafar I. Bashir · Paul Farrow · Paul Farrow
Group I mGluR Induced LTD of NMDAR-synaptic Transmission at the Schaffer Collateral but not Temperoammonic Input to CA1 Magdalena Kalinowska · Anna Francesconi · Anna Francesconi
Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets Eunsoo Won · Yong Ku Kim · Yong Ku Kim
Gut-Brain Axis in Gastric Mucosal Damage and Protection Jeffrey Burgdorf · Elizabeth M. Colechio · Patric K. Stanton · Jaak Panksepp · Jaak Panksepp
Retinal neurodegeneration in the course of diabetes - pathogenesis and clinical perspective Donald C. Goff · Donald C. Goff
EDITORIAL Epigenetics and Neuro-behavioral Modulations Laura Orsolini · Fabiola Sarchione · Federica Vellante · Michele Fornaro · Ilaria Matarazzo · Giovanni Martinotti · Alessandro Valchera · Marco Di Nicola · Alessandro Carano · Massimo Di Giannantonio · Giampaolo Perna · Luigi Olivieri · Domenico De Berardis · Domenico De Berardis
Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration Zhang Ll · Canning Sd · Wang Xp · Wang Xp
Freezing of Gait in Parkinsonism and its Potential Drug Treatment Kalkena Sivanesam · Niels H. Andersen · Niels H. Andersen
Modulating the Amyloidogenesis of α-Synuclein Ole Köhler · Jesper Krogh · Ole Mors · Michael Eriksen Benros · Michael Eriksen Benros
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment Morin N · Marc Morissette · Grégoire L · Di Paolo T · Di Paolo T
mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias Agnieszka Dominiak · Anna Wilkaniec · Piotr Wroczyński · Agata Adamczyk · Agata Adamczyk
Selenium in the Therapy of Neurological Diseases. Where is it Going Carlos Roncero · Alfonso C. Abad · Antonio Padilla-Mata · Elena Ros-Cucurull · Carmen Barral · M. Casas · Lara Grau-López · Lara Grau-López
Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior Ewa Bojanowska · Joanna Ciosek · Joanna Ciosek
Metabotropic Glutamate Receptors and Interacting Proteins in Epileptogenesis Seyed Fazel Nabavi · Silvia Tejada · William N. Setzer · Olga Gortzi · Antoni Sureda · Nady Braidy · Maria Daglia · Azadeh Manayi · Seyed Mohammad Nabavi · Seyed Mohammad Nabavi
Anti-Oxidants in Parkinsons Disease Therapy: A Critical Point of View Cássia Righy · Marcelo T. Bozza · Marcus F. Oliveira · Fernando A. Bozza · Fernando A. Bozza
Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within? Brittany A. Jaso · Mark J. Niciu · Nicolas D. Iadarola · Erica M. Richards · Minkyung Park · Elizabeth D. Ballard · Allison C. Nugent · Rodrigo Machado-Vieira · Carlos A. Zarate · Carlos A. Zarate
Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder Bartosz Brzozowski · Agnieszka Mazur-Bialy · Robert Pajdo · Slawomir Kwiecien · Jan Bilski · Malgorzata Zwolinska-Wcislo · Tomasz Mach · Tomasz Brzozowski · Tomasz Brzozowski
Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease (IBD): Role of Brain-Gut Axis Klára Gyires · Zoltán S. Zádori · Zoltán S. Zádori
Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation Tony L. Yaksh · Casey J. Fisher · Tyler M. Hockman · Ashley J. Wiese · Ashley J. Wiese
Optic nerve and cerebral edema in the course of diabetic ketoacidosis Marianne Ronovsky · Stefanie Berger · Barbara Molz · Angelika Berger · Daniela D. Pollak · Daniela D. Pollak
Animal Models of Maternal Immune Activation in Depression Research Sufang Liu · Sufang Liu · Changsheng Li · Ying Xing · Yanqing Wang · Feng Tao · Feng Tao
Role of Neuromodulation and Optogenetic Manipulation in Pain Treatment Vyara Todorova · Arjan Blokland · Arjan Blokland
Mitochondria and Synaptic Plasticity in the Mature and Aging Nervous System Anna Földes · Kristóf Kádár · Beáta Kerémi · Ákos Zsembery · Klára Gyires · Zoltán S. Zádori · Gábor Varga · Gábor Varga
Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage Kate McDonnell-Dowling · John P. Kelly · John P. Kelly
Editorial (Thematic Issue: Epigenetics and Neuro-behavioral Modulations) Lauren Breithaupt · Christopher Hubel · Cynthia M. Bulik · Cynthia M. Bulik
Positive Emotional Learning Induces Resilience to Depression: A Role for NMDA Receptor-mediated Synaptic Plasticity Predrag Sikiric · Sven Seiwerth · Rudolf Rucman · Danijela Kolenc · Lovorka Batelja Vuletic · Domagoj Drmic · Tihomir Grgic · Sanja Strbe · Goran Zukanovic · Dalibor Crvenkovic · Goran Madzarac · Iva Rukavina · Mario Sucic · Marko Baric · Neven Starcevic · Zoran Krstonijevic · Martina Lovrić Benčić · Igor Filipcic · Dinko Stancic Rokotov · Josipa Vlainić · Josipa Vlainić
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications Burch Rm · Amin Khan M · Houck D · Yu W · Burgdorf J · Moskal · Moskal
NMDA Receptor Glycine Site Modulators as Therapeutics for Depression: Rapastinel has Antidepressant Activity without Causing Psychotomimetic Side Effects Morag Brookes · Sam Eldabe · Alan M. Batterham · Alan M. Batterham
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis Aleksandra Araszkiewicz · Dorota Zozulińska-Ziółkiewicz · Dorota Zozulińska-Ziółkiewicz
The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies Debora Cutuli · Debora Cutuli
Does the MK2-dependent Production of TNFα Regulate mGluR-dependent Synaptic Plasticity? Enza Palazzo · Ida Marabese · de Novellis · Rossi F · Sabatino Maione · Sabatino Maione
Metabotropic Glutamate Receptors 7 within the Nucleus Accumbens are Involved in Relief Learning in Rats Monika Woźniak · Francine Acher · Marcin Marciniak · Magdalena Lason-Tyburkiewicz · Piotr Gruca · Mariusz Papp · Andrzej Pilc · Joanna M. Wierońska · Joanna M. Wierońska
The Role of Levomilnacipran in the Management of Major Depressive Disorder: A Comprehensive Review Megan M. Eaton · Allison L. Germann · Ruby Arora · Lily Q. Cao · Xiaoyi Gao · Daniel J. Shin · Albert Wu · David C. Chiara · Jonathan B. Cohen · Joe Henry Steinbach · Alex S. Evers · Gustav Akk · Gustav Akk
Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients Hanne-Line Rabben · Chun-Mei Zhao · Yoku Hayakawa · Timothy C. Wang · Duan Chen · Duan Chen
Vagotomy and Gastric Tumorigenesis Rintaro Hashizume · Nalin Gupta · Nalin Gupta
Patient-derived tumor models for diffuse intrinsic pontine gliomas Joaquín Manjarrez-Marmolejo · Javier Franco-Pérez · Javier Franco-Pérez
Gap Junction Blockers: An Overview of their Effects on Induced Seizures in Animal Models Josipa Vlainić · Jelena Šuran · Toni Vlainić · Antonella Letizia Vukorep · Antonella Letizia Vukorep
Probiotics as an adjuvant therapy in major depressive disorder Miryam Nava Catorce · Goar Gevorkian · Goar Gevorkian
LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals Francesco Paolo Busardò · Chrystalla Kyriakou · Luigi Cipolloni · Simona Zaami · Paola Frati · Paola Frati
From clinical application to cognitive enhancement: The example of methylphenidate Masumi Iketani · Ikuroh Ohsawa · Ikuroh Ohsawa
Editorial (Thematic Selection: Critical Analyses of Mechanism-Based Therapies Against Parkinsons Disease: Concepts and Perspectives) Vanessa de Paula Soares · Alline C. Campos · Alline C. Campos
EDITORIAL (Thematic Issue: Retinal Neurodegeneration in the Course of Diabetes: Neuroprotection as a Potential Treatment Target) Chrystalla Kyriakou · Manuela Pellegrini · Oscar García-Algar · Enrico Marinelli · Simona Zaami · Simona Zaami
Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape Jean Lud Cadet · Jean Lud Cadet
Dysregulation of Acetylation Enzymes Inanimal Models of Psychostimulant use Disorders: Evolving Stories Francesco Matrisciano · Isabella Panaccione · Danis R. Grayson · Ferdinando Nicoletti · Alessandro Guidotti · Alessandro Guidotti
Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review Lalita Guntuku · V.G.M. Naidu · Veera Ganesh Yerra · Veera Ganesh Yerra
Mitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds David M. Moore and Connail McCrory · David M. Moore and Connail McCrory
Editorial: The Concept of Mania Across Centuries Parmeet Kaur · Saurabh Sharma · Saurabh Sharma
Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma Jennifer Fazzari · Katja Linher-Melville · Gurmit Singh · Gurmit Singh
Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis Ondrej Soukup · Michael Winder · Uday Kumar Killi · Vladimír Wsól · Daniel Jun · Kamil Kuca · Gunnar Tobin · Gunnar Tobin
Epigenetics in Brain Tumors: HDACs Take Center Stage Rachna Mehta · Abhishek Singh · István Bókkon · Birendra Nath Mallick · Birendra Nath Mallick
REM sleep and its Loss-Associated Epigenetic Regulation with Reference to Noradrenaline in Particular Leonardo Tondo · Gustavo H. Vázquez · Ross J. Baldessarini · Ross J. Baldessarini
Nutraceuticals against Neurodegeneration: A Mechanistic Insight Tessa Johung · Michelle Monje · Michelle Monje
Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets Jacob Peedicayil · Jacob Peedicayil
Epigenetic Drugs for Multiple Sclerosis Miriam Goebel-Stengel · Andreas Stengel · Andreas Stengel
Role of brain NUCB2/nesfatin-1 in the stress-induced modulation of gastrointestinal functions Hansen Chen · Suhua Qi · Jiangang Shen · Jiangang Shen
One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke Fernando Pena-Ortega · Fernando Pena-Ortega
Multiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol Malgorzata Mrugacz · Anna Bryl · Artur Bossowski · Artur Bossowski
Kappa Opioids, Salvinorin A and Major Depressive Disorder Antonio Bruno · Paolo Morabito · Edoardo Spina · Maria Rosaria Anna Muscatello · Maria Rosaria Anna Muscatello
Involvement of GABA B Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu 4 Receptor, LSP4-2022 Pope Je · Deer Tr · Amirdelfan K · McRoberts Wp · Nabeel Azeem · Nabeel Azeem
Systems Genomics Support for Immune and Inflammation Hypothesis of Depression George T. Taylor · Francesca Manzella · Francesca Manzella
Shining Light on an mGlu5 Photoswitchable NAM: A Theoretical Perspective Zsófia Majláth · Nóra Török · József Toldi · László Vécsei · László Vécsei
Memantine and kynurenic acid: Current neuropharmacological aspects Xiao-Ping Wang · Hong-Zhuan Chen · Hong-Zhuan Chen
Thematic Selection: Strategies of Current Drugs and Alternative Treatments for Neurodegenerative Diseases Aparna Areti · Veera Ganesh Yerra · Prashanth Komirishetty · Ashutosh Kumar · Ashutosh Kumar
Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies Thomas E. Salt · Thomas E. Salt
Editorial (Thematic Selection: Special Issue on Metabotropic Glutamate Receptors) Ellen Louise Hogg · Jürgen Müller · Sônia A. L. Corrêa · Sônia A. L. Corrêa
Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications John Yin · Alasdair M. Barr · Alfredo Ramos-Miguel · Ric M. Procyshyn · Ric M. Procyshyn
Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review Zhiping Zhou · Ranjodh Singh · Mark M. Souweidane · Mark M. Souweidane
Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment Simion · Nadim Wd · Benedetti H · Pichon C · Morisset-Lopez S · Baril P · Baril P
Compartmentalized Platforms for Neuro-Pharmacological Research M. Carmen Arenas · M.A. Aguilar · Sandra Montagud-Romero · Ana Mateos-García · Concepción I. Navarro-Francés · José Miñarro · Marta Rodríguez-Arias · Marta Rodríguez-Arias
Influence of the Novelty-Seeking Endophenotype on the Rewarding Effects of Psychostimulant Drugs in Animal Models Joanna Ślusarczyk · Ewa Trojan · Jakub Chwastek · Katarzyna Głombik · Agnieszka Basta-Kaim · Agnieszka Basta-Kaim
A potential contribution of chemokine network dysfunction to the depressive disorders Nadim Wd · Simion · Benedetti H · Pichon C · Baril P · Morisset-Lopez S · Morisset-Lopez S
Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus Predrag Sikiric · Predrag Sikiric
Mitochondrial Dysfunction in Depression Georgios D. Kotzalidis · Chiara Rapinesi · Valeria Savoja · Ilaria Cuomo · Alessio Simonetti · Elisa Ambrosi · Isabella Panaccione · Silvia Gubbini · Pietro De Rossi · Lavinia De Chiara · Delfina Janiri · Gabriele Sani · Alexia E. Koukopoulos · Giovanni Manfredi · Flavia Napoletano · Matteo Caloro · Lucia Pancheri · Antonella Puzella · Gemma Callovini · Gloria Angeletti · Antonio Del Casale · Antonio Del Casale
EDITORIAL (Thematic Issue: Brain Gut Axis-New View) Moreno-Fernandez Roman Dario · Tabbai Sara · Castilla-Ortega Estela · Perez-Martin Margarita · Estivill-Torrus Guillermo · Rodríguez De Fonseca Fernando · Santín Núñez Luis Javier · Pedraza Carmen · Pedraza Carmen
Nanoparticles of waste material of propolis and gelatin as a novel system for delivery of L-ascorbic acid Yong Ku Kim · Cheolmin Shin · Cheolmin Shin
Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review Imre Szabó · József Czimmer · Gyula Mózsik · Gyula Mózsik
Cellular energetical actions ofchemicalandsurgicalvagotomy in gastrointestinal mucosal damage and protection: Similarities, differences and significance for brain-gut function Mariely Hernandez · Ciro Marangoni · Marie C. Grant · Jezelle Estrada · Gianni L. Faedda · Gianni L. Faedda
Editorial (Thematic Selection: Mitochondrial Dysfunction & Neurological Disorders) Bruno A. Marichal-Cancino · Alfonso Fajardo-Valdez · Alejandra E. Ruiz-Contreras · Mónica Méndez-Díaz · Oscar Prospéro-García · Oscar Prospéro-García
Editorial (Thematic Selection: Inflammatory and Immune Responses in Depression) Bókkon I · Mallick Bn · Mallick Bn
Epigenetics and Neuro-behavioral Modulations Wataru Araki · Wataru Araki
EDITORIAL Meet Our Editorial Board Member Iwona Bs · Iwona Bs
Growth factors in pathogenesis of retinal neurodegeneration in diabetes mellitus Affiliation Siddharth Arun · Lei Liu · Gizem Donmez · Gizem Donmez
Mitochondrial Biology and Neurological Diseases Abhay Sharma · Abhay Sharma
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinsons Disease, Where Do We Stand? Jean-Marc Taymans · Elisa Greggio · Elisa Greggio

Special Issue on Programmed Cell Death in Stroke
Current Neuropharmacology | 2018
Yağmur Çetin Taş · Ihsan Solaroglu · Yasemin Gursoy-Ozdemir · Yasemin Gursoy-Ozdemir
3D-QSAR and in-silico studies of natural products and related derivatives as monoamine oxidase inhibitors
Current Neuropharmacology | 2018
Lang-Yue Hu · Wen-Li Mi · Gen-Cheng Wu · Yan-Qing Wang · Qi-Liang Mao-Ying · Qi-Liang Mao-Ying
Pharmacological Treatment Of Body Dysmorphic Disorder
Current Neuropharmacology | 2018
Kinga Sałat · Beata Gryzło · Katarzyna Kulig · Katarzyna Kulig
Experimental drugs for neuropathic pain
Current Neuropharmacology | 2018
Dahua Fan · Liping Liu · Zhengzhi Wu · Meiqun Cao · Meiqun Cao